Diarrhea

Gastroenterology·MeSH: Diarrhea

16 drugs in development·12 companies·9 clinical trials

Drug Pipeline by Phase

Approved(8)

Drug	Company
canalevia-ca1	Jaguar Health, Inc. (JAGX)
dificid	Curative Biotechnology Inc (CUBT)
Dificid	Merck & Co., Inc. (MRK)
first defense	IMMUCELL CORP /DE/ (ICCC)
loperamide	PERRIGO Co plc (PRGO)
mytesi	Jaguar Health, Inc. (JAGX)
nitazoxanide	ANI PHARMACEUTICALS INC (ANIP)
Xifaxan	Bausch Health Companies Inc. (BHC)

Phase 2(5)

Drug	Company
rotarix	GH Research PLC (GHRS)
SER-155	Seres Therapeutics, Inc. (MCRB)
travelan	Immuron Ltd (IMRN)
Travelan	UNITED THERAPEUTICS Corp (UTHR)
trivalent p2-vp8	GH Research PLC (GHRS)

Preclinical(1)

Drug	Company
np-300	Jaguar Health, Inc. (JAGX)

Phase 4(2)

Drug	Company
rifaximin soluble solid dispersion (SSD)	Bausch Health Companies Inc. (BHC)
teicoplanin	Sanofi (SNY)

BioSniper tracks 16 drugs in development for Diarrhea across 12 companies.

There are 9 clinical trials targeting Diarrhea tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.